2018 SUMMIT REGISTRATION PARTNERING PRESENTING SPEAKERS AGENDA 2017 SUMMIT ABOUT US HOTEL

ABOUT THE SUMMIT

CTIC Capital is dedicated to create valuable connections through the annual summit for US companies that are interested in raising capital and developing business relationships in China.
Get ready to pitch  
We will bring you Chinese investors (200+) who are actively searching for US investment and business collaboration opportunities. New for 2018, we will select 6-8 companies out of hundreds of applications to present and be evaluated by investors.
 
Get ready to be inspired
Impressive line up of investors from US and China to share challenges and opportunities in areas such as: Precision Medicine, Early Drug Development, Medical Devices, Cross Border M&A, Fund Raising and more.
 
Get ready to connect
One-on-One partnering system will assist you in submitting inquiries for One-on-One meetings. The system will open by December 15th, 2017.
 

CONFIRMED SPEAKERS

Randy W. Schekman (Keynote)
Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine
Professor of Molecular and Cell Biology, University of California, Berkeley
 
Kevin Chen
Managing Partner, Biotrack Capital
 
Ted Driscoll
Partner, DIGITALDX
 
Julie Papanek Grant
Partner, Canaan
 
Nanxing He
Executive Partner, Sangel Ventures
 
Patrick Heron
Managing General Partner, Frazier Healthcare Partners
 
Hongjie Hu
Investment Director, Temasek
 
James Huang
Managing Partner, KPCB China
 
Alexis Ji
Partner, lllumina Ventures
 
Clarence Kho
Managing Director, Converge Minds
 
Yanhong Lin
Founder and Managing Partner, CTIC Capital
 
Hongbo Lu
Partner, Lily Asia Ventures
 
Xiaobo Lu
Partner, Sequoia Capital China
 
Xiangyu Ouyang
Managing Director, Legend Capital
 
Amy Schulman
Entrepreneur Partner, Polaris Partners
 
Christopher Shen
Managing Partner, Qiming Venture
 
Alvin Syh
CEO, Buchang Asset Management;
General Manager, Anrich Capital Asia
 
Karen Wong
Partner, Intellectual Property, WSGR
 
Jerry Xiao
CEO, Hermed Capital
 
Grace Xu
SVP for Biomedicine Business,SanPower
Denderon Corporation Chairman
 
Jianbin Zhang
Partner, IDG Capital - Healthcare
 
Jiang Zhang
Managing Director, Ping An Venture
 
Lily Zhang
Partner, CDH Venture
 
James Zhao
Founding Partner, LYFE Capital
 
Richard Zhao
GM Strategy and Investment & SVP, Medical Device, Fosun Pharma
 

PRELIMINARY AGENDA

MORNING SESSION
  08:00-09:30AM Registration / Networking / Breakfast
  09:30-09:45AM Welcome and CTIC Introduction and Reflection on Cross-border Investments
    Yanhong Lin, Managing Partner, CTIC Capital
  09:45-10:30AM Keynote: Prospects for Use of Exosomes in Cancer Diagnosis and Treatment
    Randy W. Schekman, Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine
  10:30-11:15AM Panel Discussion I: Chinese Investment & M&A Opportunities – Where is the money?
    James Huang, Managing Partner, KPCB China
Alexis Ji, Partner, Illumina Ventures
Xiaobo Lu, Partner, Sequoia Capital China
Xiangyu Ouyang, Managing Director, Legend Capital
Jerry Xiao, CEO, Hermed Capital
  11:15-12:00PM Panel Discussion II: Successful Equity Investments and M&A & why others failed
    Karen Wong, Partner, Intellectual Property, WSGR
Hongbo Lu, Partner, Lily Asia Ventures
Christopher Shen, Managing Partner, Qiming Venture
Alvin Syh, CEO, Buchang Asset Management; General Manager, Anrich Capital Asia
Grace Xu, SVP for Biomedicine Business, SanPower; Denderon Corporation Chairman
Richard Zhao, GM Strategy and Investment & SVP, Medical Device, Fosun Pharma
  12:00-01:15PM Lunch / Special China Session hosted by WSGR
AFTERNOON SESSION
  01:15-02:15PM Company Presentations (3 companies – 7 minutes presenting plus 13 minutes feedbacks from participating investors)
    Presenting Companies TBD
Investor Advisor Panel
Kevin Chen, Managing Partner, Biotrack Capital
Nanxing He, Executive Partner, Sangel Ventures
Hongjie Hu, Investment Director, Temasek
  02:15-03:00PM Panel Discussion III: US Healthcare Investment Trend – Where would the US VCs invest in healthcare?
    Ted Driscoll, Partner, DigitalDx
Julie Papanek Grant, Partner, Canaan
Patrick Heron, Managing General Partner, Frazier Healthcare Partners
Amy Schulman, Entrepreneur Partner, Polaris Partners
Frank Torti, Partner, NEA
  03:00-03:15PM Afternoon Break
  03:15-04:15PM Company Presentations (3 companies – 7 minutes presenting plus 13 minutes feedbacks from participating investors)
    Presenting Companies TBD
Investor Advisor Panel
Jianbin Zhang, Partner, IDG Capital – Healthcare
Jiang Zhang, Managing Director, Ping An Venture
Lily Zhang, Partner, CDH Venture
  04:15-05:00PM Panel Discussion IV: Cross-border Business Development, Joint Venture, and licensing opportunities
  05:00-05:15PM Closing
  05:15-07:00PM Networking
 

Overview of 2017 CTIC Capital
Healthcare Investment Summit

 

Feedbacks from our 2017 Summit Attendees

CTIC CAPITAL

     
 
CTIC Capital is a Silicon Valley based boutique private equity consulting firm focusing on healthcare, Internet technology, and renewable energy. Leveraging our Trans-Pacific network and local expertise, CTIC Capital helps enterprises in US and China in funding, M&A, and strategic partnership development. Our goal is to be the trusted advisor to companies for US-China cross-border investment and partnership opportunities.
 
     
 

CONTACT US

 
ning.feng@cticcapital.com
yanhong.lin@cticcapital.com